Sign Up Today and Learn More About AVIVA Biosciences Stock
Invest in or calculate the value of your shares in AVIVA Biosciences or other pre-IPO companies through EquityZen's platform.
AVIVA Biosciences Stock
AVIVA Biosciences invents devices and assays to advance the study of eukaryotic cells.
About AVIVA Biosciences Stock
Founded
1997
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
AVIVA Biosciences Press Mentions
Stay in the know about the latest news on AVIVA Biosciences
Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at ENDO 2025
venturebeat • Jul 15, 2025
Circulating Tumor Cell Market Set to Surge to $43.5 Billion by 2033 at a 13.9% CAGR
einpresswire • Feb 18, 2025
Global Next Generation Cancer Diagnostics Industry to 2025
prnewswire • Aug 28, 2020
AVIVA Biosciences Management
Leadership team at AVIVA Biosciences
CTO
Brad Sippy
CEO
Judith Boice
Join now and verify your accreditation status to gain access to:
- AVIVA Biosciences Current Valuation
- AVIVA Biosciences Stock Price
- AVIVA Biosciences Management
- Available deals in AVIVA Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- AVIVA Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- AVIVA Biosciences Revenue and Financials
- AVIVA Biosciences Highlights
- AVIVA Biosciences Business Model
- AVIVA Biosciences Risk Factors
- AVIVA Biosciences Research Report from SACRA Research
Trading AVIVA Biosciences Stock
How to invest in AVIVA Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like AVIVA Biosciences through EquityZen funds. These investments are made available by existing AVIVA Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AVIVA Biosciences stock?
Shareholders can sell their AVIVA Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."